CLEVELAND HEALTH-TECH CORRIDOR: STRATEGIC LOCATION FOR INNOVATION
The 3-mile 1600-acre Cleveland Health-Tech Corridor (HTC) is a prime location for biomedical, healthcare and technology companies looking to take advantage of close proximity to 4 world-class healthcare institutions including the Cleveland Clinic and University Hospitals, 9 business incubators, 4 academic centers, and more than 130 high-tech companies engaged in the business of innovation.
The HTC engages 9 neighborhoods, over 50,000 students, and more than 50,000 medical and technical employees. $450 Million is supplied in annual research, $4,000 is provided in clinical trials, and $3.8 Billion has been secured for the HTC since 2007.
Biomedical companies with headquarters in the HTC include:
Arteriocyte Medical System - focuses on developing commercially available stem cell based therapies using multiple sources of adult derived stem cells for delivery to injured tissues in order to speed repair and improve function. In seven short years, the company has grown from one employee to more than 67 employees located throughout the world and has rapidly transitioned from a basic research project into a fully integrated R&D and commercial product company.
Athersys Inc. – a clinical stage public biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The company is developing MultiStem®, a patented, adult-derived "off-the-shelf" stem cell product platform for multiple disease indications.
CardioInsight Technologies, Inc. - commercializing a breakthrough patented electrocardiographic imaging technology that will significantly improve the diagnosis and treatment of a number of critical heart conditions. The company’s Electrocardiographic Mapping (ECM) technology non-invasively images electrical activity on the surface of the heart, combining body surface electrical data and chest CT scans
Explorys - provides a secure cloud-computing platform for data management, analytics and outcomes measurement in the healthcare industry. Its clients include pharmaceutical companies, medical device firms, contract research organizations and provider health systems including Cleveland Clinic, MetroHealth, Summa and University Hospitals.
Juventas Therapeutics - a privately-held clinical-stage biotechnology company developing a pipeline of regenerative therapies to treat life-threatening diseases. Founded in 2007 with exclusively licensed intellectual property developed at the Cleveland Clinic, Juventas has secured more than $10 million in venture capital and grant funding to transition its therapeutic platform from concept to initiation of mid-stage clinical trials.
Simbionix - a leader in the development and delivery of innovative and effective virtual reality simulation products and solutions for clinical education and training of medical professionals. Fueled by growing demand for its technology, Simbionix is expanding the size of its corporate headquarters in the Baker Building, located in Cleveland’s Health-Tech Corridor - and is also moving into a new research and development facility in Israel.